The United Nations Commission on Narcotic Drugs voted in
favour of scheduling three 2C-phenethylamines derivatives, 25B-NBOMe, 25C-NBOMe, and
25I-NBOMe, under Schedule I to the United Nations Convention on Psychotropic
Substances 1971. 2C-phenethylamines are potent synthetic hallucinogens having both
stimulant and hallucinogenic properties. Considered as "designer drugs", they are
emerging in the market at a rapid pace. These designer drugs are readily available for sale
on the internet as "research chemicals" and at raves, nightclubs and head shops. Around
the world, these products have been associated with significant health and safety risks.
There are no known legitimate therapeutic or industrial uses and only limited scientific and
research uses for 2C-phenethylamines.
This notice provides interested stakeholders with the opportunity to comment on Health
Canada's intent to pursue amendments to Schedule III to the CDSA and the Schedule to
Part J of the FDR to include 2C-phenethylamines and their salts, derivatives, isomers and
salts of derivatives and isomers. This would include 25B-NBOMe, 25C-NBOMe and
25I-NBOMe and their salts.